Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Pharmacological Research
|
November 10, 2021
Similarities and differences upon binding of naturally occurring Δ<sup>9</sup>-tetrahydrocannabinol-derivatives to cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors
Iu Raïch, Rafael Rivas-Santisteban, Alejandro Lillo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 26, 2023
Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs
Claudia Gioé-Gallo, Sandra Ortigueira, José Brea, et al.
Journal of Medicinal Chemistry
|
June 24, 2020
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A<sub>2B</sub> Adenosine Receptor Antagonists
Ana Mallo-Abreu, Rubén Prieto-Díaz, Willem Jespers, et al.
Journal of Medicinal Chemistry
|
June 10, 2021
Potent and Subtype-Selective Dopamine D<sub>2</sub> Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, et al.
European Journal of Medicinal Chemistry
|
January 19, 2023
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
Angewandte Chemie (International Ed. in English)
|
June 17, 2020
X-Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A<sub>2A</sub> Adenosine Receptor Antagonists
Willem Jespers, Grégory Verdon, Jhonny Azuaje, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2022
Exploring Non-orthosteric Interactions with a Series of Potent and Selective A<sub>3</sub> Antagonists
Darío Miranda-Pastoriza, Rodrigo Bernárdez, Jhonny Azuaje, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 5, 2024
Exploring Biginelli-based scaffolds as A<sub>2B</sub> adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents
Rubén Prieto-Díaz, Hugo Fojo-Carballo, Maria Majellaro, et al.
Journal of Medicinal Chemistry
|
January 24, 2022
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A<sub>1</sub> Antagonists
Cristina Val, Carlos Rodríguez-García, Rubén Prieto-Díaz, et al.
Journal for Immunotherapy of Cancer
|
May 17, 2022
A<sub>2B</sub> adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
Apple Hui Min Tay, Rubén Prieto-Díaz, Shiyong Neo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Pharmacological Research
|
November 10, 2021
Similarities and differences upon binding of naturally occurring Δ<sup>9</sup>-tetrahydrocannabinol-derivatives to cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors
Iu Raïch, Rafael Rivas-Santisteban, Alejandro Lillo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 26, 2023
Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs
Claudia Gioé-Gallo, Sandra Ortigueira, José Brea, et al.
Journal of Medicinal Chemistry
|
June 24, 2020
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A<sub>2B</sub> Adenosine Receptor Antagonists
Ana Mallo-Abreu, Rubén Prieto-Díaz, Willem Jespers, et al.
Journal of Medicinal Chemistry
|
June 10, 2021
Potent and Subtype-Selective Dopamine D<sub>2</sub> Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, et al.
European Journal of Medicinal Chemistry
|
January 19, 2023
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
Angewandte Chemie (International Ed. in English)
|
June 17, 2020
X-Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A<sub>2A</sub> Adenosine Receptor Antagonists
Willem Jespers, Grégory Verdon, Jhonny Azuaje, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2022
Exploring Non-orthosteric Interactions with a Series of Potent and Selective A<sub>3</sub> Antagonists
Darío Miranda-Pastoriza, Rodrigo Bernárdez, Jhonny Azuaje, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 5, 2024
Exploring Biginelli-based scaffolds as A<sub>2B</sub> adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents
Rubén Prieto-Díaz, Hugo Fojo-Carballo, Maria Majellaro, et al.
Journal of Medicinal Chemistry
|
January 24, 2022
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A<sub>1</sub> Antagonists
Cristina Val, Carlos Rodríguez-García, Rubén Prieto-Díaz, et al.
Journal for Immunotherapy of Cancer
|
May 17, 2022
A<sub>2B</sub> adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
Apple Hui Min Tay, Rubén Prieto-Díaz, Shiyong Neo, et al.
Page
of 3